drugset / Trial / NCT02328651

Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease

NCT02328651

RandomizedParallel-groupSingle-blindTreatment

Summary

This is a single-blinded randomized trial aiming to evaluate the effectiveness of Xiaoer Jiebiao Oral liquid in combination with Ribavirin treatment on patients with hand-foot-mouth disease compared with the controlgroup that recieve only libavirin treatment.

Timeline

Start
2014-10
Primary completion
2018-04-30
Completion
2018-05-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ribavirin Small molecule 15 mg/kg Intravenous
Subject Xiaoer Jiebiao Oral Liquid Unknown 5 ml Oral